A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer
Markus Büchler, Helmut Friess, Karl‐Heinz ‐H Schultheiss, Christoph Gebhardt, Robert Kübel, Karl‐Heinz ‐H Muhrer, Martin Winkelmann, Theo Wagener, Rainer Klapdor, Martin Kaul, Günther Müller, Gregor Schulz, Hans G. Beger
Research output: Contribution to journal › Article › peer-review
95Scopus
citations
Fingerprint
Dive into the research topics of 'A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer'. Together they form a unique fingerprint.